DAX24.122 +0,4%ESt505.454 ±0,0%Top 10 Crypto14,84 +2,4%Dow41.860 -1,9%Nas18.873 -1,4%Bitcoin95.661 +1,2%Euro1,1324 -0,1%Öl64,58 -1,6%Gold3.317 +0,1%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 RENK RENK73 NVIDIA 918422 D-Wave Quantum A3DSV9 HENSOLDT HAG000 BYD A0M4W9 Tesla A1CX3T Infineon 623100 Lufthansa 823212 Deutsche Telekom 555750 Siemens Energy ENER6Y Deutsche Bank 514000 Allianz 840400 Bayer BAY001 BASF BASF11
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
24.100-Punkte-Marke geknackt: DAX schließt mit neuem Rekord -- Wall Street letztlich tiefer -- DeuBa bewertet wieder Intel -- Xpeng, Wolfspeed, Infineon, NVIDIA, Rheinmetall, Bitcoin im Fokus
Top News
Infineon-Aktie stark: Infineon und NVIDIA arbeiten bei Stromversorgung für KI-Server zusammen Infineon-Aktie stark: Infineon und NVIDIA arbeiten bei Stromversorgung für KI-Server zusammen
freenet-Aktie schwächelt: freenet hält nach solidem Jahresstart an Prognose fest freenet-Aktie schwächelt: freenet hält nach solidem Jahresstart an Prognose fest
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil
Kreislaufwirtschaft als Investmentchance: Jetzt nachhaltig handeln, Renditechancen nutzen und Portfolio zukunftssicher aufstellen!

Jazz Pharmaceuticals Aktie

NeuKaufenVerkaufen
Aktien-Sparplan anlegen
95,28 EUR -3,04 EUR -3,09 %
FSE
108,26 USD -2,81 USD -2,53 %
BTT
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!
JETZT LOSLEGEN
Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handelnSmartphone

Marktkap.5,97 Mrd. EUR

KGV14,24Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA1JS1K

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINIE00B4Q5ZN47

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolJAZZ

Jazz Pharmaceuticals Aktien News

DatumMeistgelesen
PR NewswirePharmaMar gibt positive und statistisch signifikante Ergebnisse zum Gesamtüberleben und zum progressionsfreien Überleben für die Kombination aus Zepzelca® (Lurbinectedin) und Atezolizumab in der E...
PR NewswirePharmaMar Announces Positive and Statistically Significant Overall Survival and Progression-Free Survival Results for Zepzelca® (lurbinectedin) and Atezolizumab Combination in First-Line Maintenan...
PR NewswireJazz Pharmaceuticals Announces Statistically Significant Overall Survival and Progression-Free Survival Results for Zepzelca® (lurbinectedin) and Atezolizumab Combination in First-Line Maintenance...
PR NewswireJazz Pharmaceuticals Presents Updated Phase 2 Data for Zanidatamab Demonstrating Increased mPFS in HER2-Positive Metastatic Gastroesophageal Adenocarcinoma at ESMO 2024
PR NewswireJazz Pharmaceuticals to Present Advancements in Solid Tumor Oncology Research at ESMO 2024
PR NewswireJazz Pharmaceuticals to Present New Data Demonstrating Improved Epilepsy Outcomes with Epidiolex®/Epidyolex® (cannabidiol) at the European Epilepsy Congress 2024
PR NewswireJazz Pharmaceuticals Provides Update on Cannabidiol Oral Solution Phase 3 Trial in Japan in Treatment-Resistant Epilepsies
PR NewswireJazz Pharmaceuticals to Participate in Upcoming September Investor Conferences
PR NewswireJazz Pharmaceuticals to Participate in Upcoming September Investor Conferences
PR NewswireJazz Pharmaceuticals Announces Second Quarter 2024 Financial Results and Updates 2024 Financial Guidance
PR NewswireJazz Pharmaceuticals Announces Second Quarter 2024 Financial Results and Updates 2024 Financial Guidance
PR NewswireJazz Pharmaceuticals Shareholders Elect Laura Hamill to the Company's Board of Directors at Annual General Meeting
PR NewswireJazz Pharmaceuticals Announces Successful Completion of Term Loan Repricing and Irrevocable Election of Settlement Method for the 2.000% Exchangeable Senior Notes due 2026
PR NewswireJazz Pharmaceuticals Announces Successful Completion of Term Loan Repricing and Irrevocable Election of Settlement Method for the 2.000% Exchangeable Senior Notes due 2026
PR NewswireJazz Pharmaceuticals to Report 2024 Second Quarter Financial Results on July 31, 2024
PR NewswireJazz Pharmaceuticals to Report 2024 Second Quarter Financial Results on July 31, 2024
PR NewswireJazz Pharmaceuticals Promotes Samantha Pearce to Chief Commercial Officer
PR NewswireJazz Pharmaceuticals Promotes Samantha Pearce to Chief Commercial Officer
PR NewswireJazz Pharmaceuticals Provides Update on Phase 2b Trial of Investigational Suvecaltamide (JZP385) in Essential Tremor
PR NewswireJazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024
PR NewswireJazz Pharmaceuticals Showcases Pioneering Research in Sleep Medicine at SLEEP 2024
PR NewswireJazz Pharmaceuticals to Participate in Upcoming June Investor Conferences
PR NewswireJazz Pharmaceuticals to Participate in Upcoming June Investor Conferences
PR NewswireZanidatamab Granted Priority Review for HER2-Positive Metastatic Biliary Tract Cancer
PR NewswireJazz Pharmaceuticals Announces Collaboration with Life Science Cares to Improve the Wellbeing of Under Resourced Communities through Employee Volunteerism
PR NewswireJazz Pharmaceuticals to Participate in the BofA Securities 2024 Health Care Conference
PR NewswireJazz Pharmaceuticals to Participate in the BofA Securities 2024 Health Care Conference
PR NewswireJazz Pharmaceuticals Announces First Quarter 2024 Financial Results and Affirms 2024 Financial Guidance
PR NewswireJazz Pharmaceuticals Announces First Quarter 2024 Financial Results and Affirms 2024 Financial Guidance
PR NewswireJazz Pharmaceuticals to Present Data Across Growing Oncology Pipeline and Portfolio at ASCO 2024
PR NewswireJazz Pharmaceuticals to Report 2024 First Quarter Financial Results on May 1, 2024
PR NewswireJazz Pharmaceuticals to Report 2024 First Quarter Financial Results on May 1, 2024
PR NewswireJazz Pharmaceuticals to Showcase Expansive Neuroscience Portfolio at American Academy of Neurology Annual Meeting
PR NewswireJazz Pharmaceuticals Completes Zanidatamab Biologics License Application for Previously Treated HER2-Positive Metastatic Biliary Tract Cancer
PR NewswireJazz Pharmaceuticals to Host Virtual Zanidatamab R&D Day on Tuesday, March 19, 2024
PR NewswireJazz Pharmaceuticals to Host Virtual Zanidatamab R&D Day on Tuesday, March 19, 2024
PR NewswireJazz Pharmaceuticals Appoints Philip Johnson as Chief Financial Officer
PR NewswireJazz Pharmaceuticals Appoints Philip Johnson as Chief Financial Officer
PR NewswireJazz Pharmaceuticals to Participate in Upcoming March Investor Conferences
PR NewswireJazz Pharmaceuticals to Participate in Upcoming March Investor Conferences
Wer­bung

Jazz Pharmaceuticals News

Jazz Pharmaceuticals News: auf dieser Seite finden Sie alle Jazz Pharmaceuticals News und Nachrichten zur Jazz Pharmaceuticals Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Jazz Pharmaceuticals News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Jazz Pharmaceuticals News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.